课题基金 / 基金详情

Diagnostic and Predictive Utility of Serum Biomarkers and Magnetic Resonance Imaging Predictors for Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis

血清生物标志物和磁共振成像预测因子对复发缓解型多发性硬化症患者认知障碍的诊断和预测效用

批准号：

486263

负责人：

Sahoo Saswat

金额：

$1.27万

依托单位：

University of Alberta

依托单位国家：

加拿大

项目类别：

Studentship Programs

财政年份：

2022

资助国家：

加拿大

项目状态：

已结题

起止时间：

2022-12-01 至 2023-12-01

来源：

https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486263&lang=en

关键词：

Biomarkers Cognitive Impairment Glial Fibrillary Acidic Protein Humans Imaging Biomarkers Magnetic Resonance Imaging Multiple Sclerosis Neurofilament Light Chain Relapsing-Remitting Multiple Sclerosis Serum Biomarkers

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Cognitive impairment (CI) is a clinical manifestation of Multiple Sclerosis (MS) that has received little attention compared to its other symptoms. There has been a growing interest in being able to detect current and future CI by simply measuring specifi

期刊论文(0)

专著(0)

科研奖励(0)

会议论文